Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9218)
All Articles published online
|
Publishing Process of This Article
|
Oct 15, 2021 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Perales S, Torres C, Jimenez-Luna C, Prados J, Martinez-Galan J, Sanchez-Manas JM, Caba O. Liquid biopsy approach to pancreatic cancer. World J Gastrointest Oncol 2021; 13(10): 1263-1287 [PMID: 34721766 DOI: 10.4251/wjgo.v13.i10.1263] |
|---|---|
| URL: | https://www.wjgnet.com/2218-5836/full/v13/i10/1263.htm |
| Number | Citing Articles |
| 1 |
Nathália Faro de Brito, Luis Felipe Ribeiro Pinto, Matias Eliseo Melendez. Biosensors for liquid biopsy of pancreatic cancer. Microchemical Journal 2024; 196: 109679 doi: 10.1016/j.microc.2023.109679
|
| 2 |
Seyed Mohammad Amin Mahdian, Azam Mahmoudi-Aznaveh, Seyed Mojtaba Mousavi, Bagher Larijani, Zahra Azizi, Hamid Akbari Javar. Plasma treatment can efficiently increase the attachment of pancreatic circulatory tumor cells to the surface. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-01988-4
|
| 3 |
Hiroki Ueda, Hidenori Takahashi, Shogo Kobayashi, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi. miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic Cancer. Annals of Surgical Oncology 2025; 32(2): 720 doi: 10.1245/s10434-024-16115-w
|
| 4 |
Marta Toledano-Fonseca, Elena Brozos-Vázquez, María Victoria García-Ortiz, Nicolás Costa-Fraga, Ángel Díaz-Lagares, Antonio Rodríguez-Ariza, Rafael López-López, Enrique Aranda. Unveilling the potential of liquid biopsy in pancreatic cancer for molecular diagnosis and treatment guidance. Critical Reviews in Oncology/Hematology 2025; 212: 104807 doi: 10.1016/j.critrevonc.2025.104807
|
| 5 |
A. V. Shabunin, V. V. Ptushkin, M. M. Tavobilov, K. S. Titov, Ju. N. Kobzev, A. A. Karpov, E. B. Kudryash. The role of circulating tumor DNA in diagnosis and optimization of treatment of localized and local pancreatic cancer. Russian Journal of Biotherapy 2023; 22(2): 27 doi: 10.17650/1726-9784-2023-22-2-27-33
|
| 6 |
Wei Jin, Yuting Fu, Sisi Ge, Han Sun, Kai Pang, Xunbin Wei. In vivo fluorescence flow cytometry reveals that the nanoparticle tumor vaccine OVA@HA-PEI effectively clears circulating tumor cells. Journal of Innovative Optical Health Sciences 2024; 17(06) doi: 10.1142/S1793545824500172
|
| 7 |
Jeremy W. Roy, Gabriel Wajnberg, Alexie Ouellette, Julie Emilie Boucher, Jacynthe Lacroix, Simi Chacko, Anirban Ghosh, Rodney J. Ouellette, Stephen M. Lewis. Small RNA sequencing analysis of peptide-affinity isolated plasma extracellular vesicles distinguishes pancreatic cancer patients from non-affected individuals. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-36370-3
|
| 8 |
Nicholas Aderinto, Muili O. Abdulbasit, Deji Olatunji, Mariam Edun. Unveiling the potential of galectin-3 as a diagnostic biomarker for pancreatic cancer: a review. Annals of Medicine & Surgery 2023; 85(11): 5557 doi: 10.1097/MS9.0000000000001363
|
| 9 |
Mark Jain, David Atayan, Tagir Rakhmatullin, Tatyana Dakhtler, Pavel Popov, Pavel Kim, Mikhail Viborniy, Iuliia Gontareva, Larisa Samokhodskaya, Vyacheslav Egorov. Cell-Free Tumor DNA Detection-Based Liquid Biopsy of Plasma and Bile in Patients with Various Pancreatic Neoplasms. Biomedicines 2024; 12(1): 220 doi: 10.3390/biomedicines12010220
|
| 10 |
Mustafa Aydemir, Ali İhsan Kömür, Emine Selda Gündüz, Ceren Karaman, Onur Karaman. Breaking the Silence: AI-Enhanced Multi-Omics biosensors for liquid Biopsy-Based early diagnosis of pancreatic cancer. Microchemical Journal 2025; 215: 114118 doi: 10.1016/j.microc.2025.114118
|
| 11 |
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, Reza Ghanbari, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Pauli Puolakkainen, Sakari Knuutila. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. Biomolecules 2022; 12(5): 652 doi: 10.3390/biom12050652
|
| 12 |
Hiroki Ueda, Hidenori Takahashi, Ryoto Sakaniwa, Tetsuhisa Kitamura, Shogo Kobayashi, Yoshito Tomimaru, Masahiko Kubo, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Tadafumi Asaoka, Takehiro Noda, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi. Preoperative treatment response prediction for pancreatic cancer by multiple microRNAs in plasma exosomes: Optimization using machine learning and network analysis. Pancreatology 2024; 24(7): 1097 doi: 10.1016/j.pan.2024.09.009
|
| 13 |
Folnetti A. Alvarez, Hussein Kaddour, Yuan Lyu, Christina Preece, Jules Cohen, Lea Baer, Alison T. Stopeck, Patricia Thompson, Chioma M. Okeoma. Blood plasma derived extracellular vesicles (BEVs): particle purification liquid chromatography (PPLC) and proteomic analysis reveals BEVs as a potential minimally invasive tool for predicting response to breast cancer treatment. Breast Cancer Research and Treatment 2022; 196(2): 423 doi: 10.1007/s10549-022-06733-x
|